Federal contract award
N0003024C0100
FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | PAE STRATEGIC SYSTEMS PROGRAMS |
| NAICS | 336414 — Guided Missile and Space Vehicle Manufacturing |
| PSC | 1420 — Guided Missile Components |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIXED PRICE INCENTIVE |
| Obligations | $2.9B |
| Current contract value | $3.4B |
| Potential contract value / ceiling | $5.9B |
| Start date | Sep 12, 2024 |
| Current end date | Sep 30, 2030 |
| Potential end date | Sep 30, 2030 |
| Latest award activity | Jun 3, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 58 of 58 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 3, 2026 | P00026 | $0 | THIS MODIFICATION INCLUDES A FUNDING REALIGNMENT ACTION OF $6,449,499 FOR THE TRIDENT D5 II PROGRAM UNDER CLIN 0081 FUNDS FOR RESEARCH, DEVELOPMENT, TEST, AND EVALUATION (RDT&E). |
| Jun 3, 2026 | P00026 | $0 | THIS MODIFICATION INCLUDES A FUNDING REALIGNMENT ACTION OF $6,449,499 FOR THE TRIDENT D5 II PROGRAM UNDER CLIN 0081 FUNDS FOR RESEARCH, DEVELOPMENT, TEST, AND EVALUATION (RDT&E). |
| May 6, 2026 | A00004 | $0 | FY25 TRIDENT P&DSS |
| Apr 23, 2026 | P00025 | $-2.0K | THIS MODIFICATION INCLUDES FUNDING ACTIONS FOR THE TRIDENT D5 II, D5LE2, AND W93/MK7 PROGRAM: 1) EXERCISES CONTRACT LINE ITEM NUMBER (CLIN) 57 (D5LE2), CLINS 51 (D5LE2) & 80 (W93/MK7) INCENTIVE, CLINS 0080 & 0081 FUNDING (W93/MK7), AND DEOBLIGATIONS. |
| Apr 23, 2026 | P00025 | $76.0M | THIS MODIFICATION INCLUDES FUNDING ACTIONS FOR THE TRIDENT D5 II, D5LE2, AND W93/MK7 PROGRAM: 1) EXERCISES CONTRACT LINE ITEM NUMBER (CLIN) 57 (D5LE2), CLINS 51 (D5LE2) & 80 (W93/MK7) INCENTIVE, CLINS 0080 & 0081 FUNDING (W93/MK7), AND DEOBLIGATIONS. |
| Mar 4, 2026 | P00023 | $0 | CLIN 80 INCREMENTAL FUNDING |
| Mar 4, 2026 | P00023 | $9.2M | CLIN 80 INCREMENTAL FUNDING |
| Mar 4, 2026 | P00024 | $0 | CLIN 0053 FUNDING AND CLIN 80, CLIN 0081 INCREMENTAL FUNDING |
| Mar 4, 2026 | P00024 | $954.1M | CLIN 0053 FUNDING AND CLIN 80, CLIN 0081 INCREMENTAL FUNDING |
| Dec 18, 2025 | A00003 | $0 | FY25 TRIDENT P&DSS |
| Dec 4, 2025 | P00019 | $52.8M | CLIN 80 AND 81 INCREMENTAL FUNDING |
| Dec 4, 2025 | P00019 | $0 | CLIN 80 AND 81 INCREMENTAL FUNDING |
| Nov 20, 2025 | P00018 | $25.3K | CLIN 01 AND CLIN 0051 INCENTIVE CLAIMS FUNDING PLUS ADMIN ACTIONS |
| Nov 20, 2025 | P00018 | $7.5M | CLINS 0001 AND 0051 INCENTIVE FUNDING AND OTHER ADMIN ACTIONS |
| Sep 26, 2025 | P00017 | $0 | CLIN 0077 FUNDING |
| Sep 26, 2025 | P00017 | $1.0M | CLIN 0077 FUNDING |
| Sep 16, 2025 | A00002 | $0 | FY25 TRIDENT P&DSS |
| Aug 15, 2025 | P00014 | $-39.1K | NEW SCOPE ON CLINS 0008, 0014, AND 0061 INCREMENTALLY FUND AND FULLY FUND CLINS 0008, 0014, 0023, 0061, 0080, 0081, AND 0091 ILOE OF CLINS 0081 AND 0091 PT CLIN 0077, CHANGE CLIN 0023 AND CORRECTIONS. |
| Aug 15, 2025 | P00014 | $134.2M | NEW SCOPE ON CLINS 0008, 0014, AND 0061 INCREMENTALLY FUND AND FULLY FUND CLINS 0008, 0014, 0023, 0061, 0080, 0081, AND 0091 ILOE OF CLINS 0081 AND 0091 PT CLIN 0077, CHANGE CLIN 0023 AND CORRECTIONS. |
| Aug 15, 2025 | P00015 | $0 | CLINS 0002 AND 0003 FUNDING AND CLINS 0004 AND 0014 COST VARIANCE |
| Aug 15, 2025 | P00015 | $12.4M | CLINS 0002 AND 0003 FUNDING AND CLINS 0004 AND 0014 COST VARIANCE |
| Aug 15, 2025 | P00016 | $0 | CLIN 0080, 0093, AND 0094 FUNDING |
| Aug 15, 2025 | P00016 | $4.3M | CLIN 0080, 0093, AND 0094 FUNDING |
| Jul 2, 2025 | P00013 | $0 | INCREASE THE LEVEL OF EFFORT (LOE) UNDER CLIN 0003 BY 12,258 HOURS AND INCREMENTALLY FUND CLIN 0003 2. PROCESS A DEDUCTIVE CHANGE TO REDUCE THE LEVEL OF EFFORT OF CLIN 0019 BY 79 HOURS 3. FULLY FUND CLINS 0010 AND 0019 4. INCREMENTALLY FUND CLIN 0002 |
| Jul 2, 2025 | P00013 | $32.1M | INCREASE THE LEVEL OF EFFORT (LOE) UNDER CLIN 0003 BY 12,258 HOURS AND INCREMENTALLY FUND CLIN 0003 2. PROCESS A DEDUCTIVE CHANGE TO REDUCE THE LEVEL OF EFFORT OF CLIN 0019 BY 79 HOURS 3. FULLY FUND CLINS 0010 AND 0019 4. INCREMENTALLY FUND CLIN 0002 |
| Jun 16, 2025 | P00012 | $0 | 1. INCREMENTALLY FUND CLINS 0080 AND 0085, AND 2. FULLY FUND CLIN 0009 |
| Jun 16, 2025 | P00012 | $26.5M | 1. INCREMENTALLY FUND CLINS 0080 AND 0085 AND 2. FULLY FUND CLIN 0009 |
| May 29, 2025 | P00011 | $0 | 1. INCREMENTALLY FUND CLINS 0002, 0003, AND 0010 AND 2. FULLY FUND CLINS 0004, 0005, 0007, 0017, 0038, AND 0040 |
| May 29, 2025 | P00011 | $143.2M | 1. INCREMENTALLY FUND CLINS 0002, 0003, AND 0010 AND 2. FULLY FUND CLINS 0004, 0005, 0007, 0017, 0038, AND 0040 |
| May 21, 2025 | P00010 | $0 | INCREMENTALLY FUND CLINS 0002, 0004, 0010, AND 0019. |
| May 21, 2025 | P00010 | $42.8M | INCREMENTAL FUNDING 0002, 0004, 0010, AND 0019 |
| May 20, 2025 | A00001 | $0 | FY25 TRIDENT P&DSS |
| May 15, 2025 | P00009 | $48.7M | EXERCISE CLIN 0026, INCREMENTALLY AND FULLY FUND CLINS, AND CORRECTIONS. |
| May 15, 2025 | P00009 | $541.8M | EXERCISE CLIN 0026, INCREMENTALLY AND FULLY FUND CLINS, AND MAKE CORRECTIONS. |
| Apr 28, 2025 | P00008 | $0 | INCREMENTAL FUNDING AND UPDATE LE2 CDRLS |
| Apr 28, 2025 | P00008 | $18.3M | INCREMENTAL FUNDING AND LE2 CDRL CORRECTIONS. |
| Mar 7, 2025 | P00006 | $0 | NEW SCOPE ADDED TO CLINS 0014 AND 0031 AND NEW CLIN 0085. |
| Mar 7, 2025 | P00006 | $7.4M | NEW SCOPE FOR CLIN 0014, 0031, AND NEW CLIN 0085 |
| Mar 7, 2025 | P00007 | $0 | LE2 ADMIN CORRECTIONS AND EXERCISE CLIN 0003 |
| Mar 7, 2025 | P00007 | $0 | LE2 ADMIN CORRECTIONS |
| Jan 31, 2025 | P00005 | $0 | THE FOLLOWING CLINS ADDED 50-59, 62-69, AND 71-75. |
| Jan 31, 2025 | P00005 | $383.1M | THE FOLLOWING CLINS ADDED 50-59, 62-69, AND 71-75. |
| Jan 24, 2025 | P00004 | $0 | FY25 P&DSS INCREMENTALLY FUND CLINS AND EXERCISE OPTION CLINS |
| Jan 24, 2025 | P00004 | $104.4M | FY25 P&DSS INCREMENTALLY FUND CLINS, AND EXERCISE OPTION CLINS |
| Jan 15, 2025 | P00020 | $0 | CLIN 80 AND 81 INCREMENTAL FUNDING |
| Jan 15, 2025 | P00020 | $22.2M | CLIN 80 AND 81 INCREMENTAL FUNDING |
| Jan 15, 2025 | P00021 | $0 | CLINS 0063 AND 0066 OPTION EXERCISE AND FUNDING |
| Jan 15, 2025 | P00021 | $17.4M | CLINS 0063 AND 0066 OPTION EXERCISE AND FUNDING |
| Jan 15, 2025 | P00022 | $0 | CLIN 0056 OPTION EXERCISE |
| Jan 15, 2025 | P00022 | $22.0M | CLIN 0056 OPTION EXERCISE |
| Jan 14, 2025 | P00003 | $0 | FY25 P&DSS INCREMENTAL FUNDING CLIN 0002 |
| Jan 14, 2025 | P00003 | $15.4M | FY25 PDSS CLIN 2 INCREMENTAL FUNDING AND EVM UPDATE. |
| Nov 13, 2024 | P00002 | $4.5M | FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT |
| Nov 13, 2024 | P00002 | $102.3M | FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT |
| Sep 30, 2024 | PZ0001 | $9.2M | FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT |
| Sep 30, 2024 | PZ0001 | $143.5M | FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT |
| Sep 12, 2024 | 0 | $904.9K | FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT |
| Sep 12, 2024 | 0 | $15.1M | FY25 TRIDENT PRODUCTION AND DEPLOYED SYSTEMS SUPPORT |
Estimated positioning window
Sep 30, 2029 – Mar 30, 2030
Recompete signal: . Rule-based research score; positioning dates are estimates.
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2030-09-30 (1436 days from calculation)
- +5 points
- 9 historical awards in this buyer and category group
- +15 points
- 58 recorded award transactions
- +10 points
- Latest award action: 2026-06-03
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.